ADVANCED/METASTATIC BREAST CANCER
Clinical trials for ADVANCED/METASTATIC BREAST CANCER explained in plain language.
Never miss a new study
Get alerted when new ADVANCED/METASTATIC BREAST CANCER trials appear
Sign up with your email to follow new studies for ADVANCED/METASTATIC BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New shot could replace daily pill for advanced breast cancer
Disease control Not yet recruitingThis phase 3 trial compares an injectable form of letrozole (given every 3 months) to the standard daily oral pill, both combined with ribociclib, in 300 postmenopausal women with advanced HR-positive, HER2-negative breast cancer. The goal is to see if the injection works as well…
Matched conditions: ADVANCED/METASTATIC BREAST CANCER
Phase: PHASE3 • Sponsor: Rovi Pharmaceuticals Laboratories • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
New trial aims to beat cancer fatigue with common drug
Symptom relief Not yet recruitingThis study tests whether megestrol acetate, a drug often used for appetite loss, can prevent or reduce severe tiredness in 132 women with advanced breast cancer who are starting a treatment called trastuzumab deruxtecan (T-DXd). Participants will receive either megestrol acetate …
Matched conditions: ADVANCED/METASTATIC BREAST CANCER
Phase: PHASE3 • Sponsor: Sun Yat-sen University • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC